Special Issue "Antimicrobial Resistance and Virulence - 2nd Volume"
Deadline for manuscript submissions: 31 December 2021.
Interests: antimicrobial resistance; bacterial virulence; biofilms; genomics; infections pathogenesis; food safety
Special Issues and Collections in MDPI journals
The worldwide dissemination of antimicrobial-resistant bacteria, particularly those resistant to last-resource antibiotics, is a common problem for which no immediate solution is foreseen. In 2017, the World Health Organization (WHO) published a list of antimicrobial-resistant “priority pathogens”, which include a group of microorganisms with high level resistance to multiple drugs, named ESKAPE pathogens, comprising vancomycin-resistant Enterococcus faecium (VRE), methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA), extended spectrum β-lactamase (ESBL) or carbapenem-resistant Klebsiella pneumoniae, carbapenem-resistant Acinetobacter baumannii, carbapenem-resistant Pseudomonas aeruginosa, and extended spectrum β-lactamase (ESBL)- or carbapenem-resistant Enterobacter spp. These bacteria also have the ability to produce several virulence factors which have a major influence on the outcome of infectious diseases. Bacterial resistance and virulence are interrelated since antibiotic pressure may influence bacterial virulence gene expression and, consequently, infection pathogenesis. In addition, some virulence factors contribute to an increased resistance ability, as observed in biofilm-producing strains. Surveillance of important resistant and virulent clones and associated mobile genetic elements is essential to decision-making in terms of mitigation measures to be applied for the prevention of such infections in both human and veterinary medicine, being also relevant to address the role of natural environments as important components of the dissemination cycle of these strains.
This Special Issue represents the second volume of “Antimicrobial Resistance and Virulence” and aims to publish manuscripts that further clarify the impact of bacterial antimicrobial resistance and virulence in the three areas of the One Health triad, i.e., animal, human, and environmental health.
Dr. Manuela Oliveira
Dr. Elisabete Silva
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- antimicrobial resistance
- bacterial virulence
- infection pathogenesis
- One Health